Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk.
New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.
A molecule detectable in urine may be helpful in diagnosing colon cancer.
Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.
Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.
In addition to body mass index, genetic markers of obesity may provide value in predicting endometrial cancer risk.
Accessibility Tools